Quercetin Derivatives in Combating Spinal Cord Injury: A Mechanistic and Systematic Review

Overview

Journal Life (Basel)

Specialty Biology

Date 2022 Dec 23

PMID 36556325

Authors

Sajad Fakhri

Mohammad Mehdi Gravandi

Sadaf Abdian

Seyed Zachariah Moradi

Javier Echeverria

Affiliations

Soon will be listed here.

Abstract

Spinal cord injury (SCI) possesses a complicated etiology. There is no FDA-approved treatment for SCI, and the majority of current interventions focus on reducing symptoms. During SCI, inflammation, oxidative stress, apoptosis, and autophagy are behind the secondary phase of SCI and cause serious consequences. It urges the need for providing multi-targeting agents, that possess lower side effects and higher efficacy. The plant secondary metabolites are multi-targeting agents and seem to provide new roads in combating diseases. Flavonoids are phytochemicals of continual interest to scientists in combating neurodegenerative diseases (NDDs). Flavonoids are being studied for their biological and pharmacological effects, particularly as antioxidants, anti-inflammatory agents, anti-apoptotic, and autophagy regulators. Quercetin is one of the most well-known flavonols known for its preventative and therapeutic properties. It is a naturally occurring bioactive flavonoid that has recently received a lot of attention for its beneficial effects on NDDs. Several preclinical evidence demonstrated its neuroprotective effects. In this systematic review, we aimed at providing the biological activities of quercetin and related derivatives against SCI. Detailed neuroprotective mechanisms of quercetin derivatives are also highlighted in combating SCI.

Citing Articles

Therapeutic potential of flavonoids in neuroprotection: brain and spinal cord injury focus.

Faysal M, Al Amin M, Zehravi M, Sweilam S, Arjun U, Gupta J Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40014123 DOI: 10.1007/s00210-025-03888-4.

Advancements in Antioxidant-Based Therapeutics for Spinal Cord Injury: A Critical Review of Strategies and Combination Approaches.

Shen Y, Huang Y, Cheng Y Antioxidants (Basel). 2025; 14(1).

PMID: 39857350 PMC: 11763222. DOI: 10.3390/antiox14010017.

Natural products for the treatment of allergic rhinitis: focus on cellular signaling pathways and pharmacological targets.

Moradi S, Khazaei H, Tarlan M, Jasemi S, Joshi T, Aneva I Front Pharmacol. 2024; 15:1447097.

PMID: 39403140 PMC: 11472003. DOI: 10.3389/fphar.2024.1447097.

Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway.

Fakhri S, Moradi S, Moradi S, Piri S, Shiri Varnamkhasti B, Piri S BMC Cancer. 2024; 24(1):1079.

PMID: 39223494 PMC: 11368033. DOI: 10.1186/s12885-024-12715-7.

Acellular spinal cord scaffold containing quercetin-encapsulated nanoparticles plays an anti-inflammatory role in functional recovery from spinal cord injury in rats.

Ebrahimi B, Mokhtari T, Ghaffari N, Adabi M, Hassanzadeh G Inflammopharmacology. 2024; 32(4):2505-2524.

PMID: 38702577 DOI: 10.1007/s10787-024-01478-z.

References

Fakhri S, Nouri Z, Moradi S, Akkol E, Piri S, Sobarzo-Sanchez E . Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules. 2021; 26(10). PMC: 8156180. DOI: 10.3390/molecules26102917. View

Fakhri S, Moradi S, Nouri Z, Cao H, Wang H, Khan H . Modulation of integrin receptor by polyphenols: Downstream Nrf2-Keap1/ARE and associated cross-talk mediators in cardiovascular diseases. Crit Rev Food Sci Nutr. 2022; 64(6):1592-1616. DOI: 10.1080/10408398.2022.2118226. View

Schultke E, Kamencic H, Skihar V, Griebel R, Juurlink B . Quercetin in an animal model of spinal cord compression injury: correlation of treatment duration with recovery of motor function. Spinal Cord. 2009; 48(2):112-7. DOI: 10.1038/sc.2009.111. View

Sauerbeck A, Schonberg D, Laws J, McTigue D . Systemic iron chelation results in limited functional and histological recovery after traumatic spinal cord injury in rats. Exp Neurol. 2013; 248:53-61. PMC: 5503200. DOI: 10.1016/j.expneurol.2013.05.011. View

Pour P, Fakhri S, Asgary S, Farzaei M, Echeverria J . The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases. Front Pharmacol. 2019; 10:1207. PMC: 6856223. DOI: 10.3389/fphar.2019.01207. View

Yao S, Wang L, Chen Q, Lu T, Pu X, Luo C . The effect of mild hypothermia plus rutin on the treatment of spinal cord injury and inflammatory factors by repressing TGF-β/smad pathway. Acta Cir Bras. 2021; 36(3):e360307. PMC: 8112105. DOI: 10.1590/ACB360307. View

Zhao H, Mei X, Yang D, Tu G . Resveratrol inhibits inflammation after spinal cord injury via SIRT-1/NF-κB signaling pathway. Neurosci Lett. 2021; 762:136151. DOI: 10.1016/j.neulet.2021.136151. View

Figueira I, Menezes R, Macedo D, Costa I, Dos Santos C . Polyphenols Beyond Barriers: A Glimpse into the Brain. Curr Neuropharmacol. 2016; 15(4):562-594. PMC: 5543676. DOI: 10.2174/1570159X14666161026151545. View

Muto N, Matsuoka Y, Arakawa K, Kurita M, Omiya H, Taniguchi A . Quercetin Attenuates Neuropathic Pain in Rats with Spared Nerve Injury. Acta Med Okayama. 2018; 72(5):457-465. DOI: 10.18926/AMO/56243. View

10.

Ay M, Luo J, Langley M, Jin H, Anantharam V, Kanthasamy A . Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease. J Neurochem. 2017; 141(5):766-782. PMC: 5643047. DOI: 10.1111/jnc.14033. View

11.

Winkler T, Sharma H, Stalberg E, Badgaiyan R, Gordh T, Westman J . An L-type calcium channel blocker, nimodipine influences trauma induced spinal cord conduction and axonal injury in the rat. Acta Neurochir Suppl. 2004; 86:425-32. DOI: 10.1007/978-3-7091-0651-8_88. View

12.

Sandhir R, Mehrotra A . Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease. Biochim Biophys Acta. 2012; 1832(3):421-30. DOI: 10.1016/j.bbadis.2012.11.018. View

13.

Burnside E, de Winter F, Didangelos A, James N, Andreica E, Layard-Horsfall H . Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury. Brain. 2018; 141(8):2362-2381. PMC: 6061881. DOI: 10.1093/brain/awy158. View

14.

Khan M, Orhan I, Senol F, Kartal M, Sener B, Dvorska M . Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem Biol Interact. 2009; 181(3):383-9. DOI: 10.1016/j.cbi.2009.06.024. View

15.

Civi S, Emmez G, Dere U, Borcek A, Emmez H . Effects of quercetin on chronic constriction nerve injury in an experimental rat model. Acta Neurochir (Wien). 2016; 158(5):959-65. DOI: 10.1007/s00701-016-2761-0. View

16.

Schultke E, Griebel R, Juurlink B . Quercetin attenuates inflammatory processes after spinal cord injury in an animal model. Spinal Cord. 2010; 48(12):857-61. DOI: 10.1038/sc.2010.45. View

17.

Juurlink B, Paterson P . Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med. 1999; 21(4):309-34. DOI: 10.1080/10790268.1998.11719540. View

18.

Moradi S, Jalili F, Farhadian N, Joshi T, Wang M, Zou L . Polyphenols and neurodegenerative diseases: focus on neuronal regeneration. Crit Rev Food Sci Nutr. 2021; 62(13):3421-3436. DOI: 10.1080/10408398.2020.1865870. View

19.

Kawabata K, Mukai R, Ishisaka A . Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food Funct. 2015; 6(5):1399-417. DOI: 10.1039/c4fo01178c. View

20.

Fakhri S, Moradi S, Ash-Rafzadeh A, Bishayee A . Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review. Pharmacol Res. 2021; 177:105961. DOI: 10.1016/j.phrs.2021.105961. View